SILA analyses examining cognitive decline across the three domains, anchored to estimated age of tau onset (Section 2.4.5), are presented in Figure 5 to illustrate group differences in cognitive trajectories between AD+sLATE– and AD+sLATE+ individuals. This evidence concerns the gene MAPT and Alzheimer disease.